Insider Buying: Fisher & Paykel Healthcare Co. Limited (ASX:FPH) Insider Acquires 1,000 Shares of Stock

Fisher & Paykel Healthcare Co. Limited (ASX:FPH) insider Graham McLean bought 1,000 shares of Fisher & Paykel Healthcare stock in a transaction dated Monday, February 17th. The stock was acquired at an average cost of A$32.30 ($20.57) per share, for a total transaction of A$32,300.00 ($20,573.25).

Fisher & Paykel Healthcare Stock Performance

The company has a debt-to-equity ratio of 10.75, a current ratio of 1.83 and a quick ratio of 0.79. The firm has a market cap of $20.55 billion, a price-to-earnings ratio of 157.79, a price-to-earnings-growth ratio of 4.47 and a beta of 0.42.

Fisher & Paykel Healthcare Increases Dividend

The business also recently disclosed a Interim dividend, which was paid on Tuesday, December 17th. Shareholders of record on Tuesday, December 17th were given a $0.167 dividend. This represents a yield of 0.49%. The ex-dividend date was Wednesday, December 4th. This is a boost from Fisher & Paykel Healthcare’s previous Interim dividend of $0.17. Fisher & Paykel Healthcare’s dividend payout ratio (DPR) is presently 180.95%.

Fisher & Paykel Healthcare Company Profile

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital.